Complement deficiency in pediatric-onset systemic lupus erythematosus
- PMID: 29692593
- PMCID: PMC5896194
- DOI: 10.4103/JLP.JLP_171_17
Complement deficiency in pediatric-onset systemic lupus erythematosus
Abstract
Background: Pediatric-onset systemic lupus erythematosus (pSLE) accounts for about 10%-20% of all patients with SLE. Deficiencies in early complement components of the classical pathway are the strong genetic risk factor for the development of SLE. In this study, clinical and laboratory manifestations of both complement-deficient and normal complement pSLE patients were compared.
Materials and methods: To investigate clinical and immunological manifestations of pSLE in Iran, 36 consecutive pSLE patients (onset before 18 years) who were followed up over a period of 2 years, were studied. Complement C1q and C2 levels were measured using radial immunodifusion assay and complement C3 and C4 levels were measured using nephelometry. Medical records were retrospectively evaluated from patient database of Children Medical Center Hospital. Data were assessed through descriptive analysis (confidence interval = 95%), paired t-test, and Pearson correlation test.
Results: Twenty-one patients (58%) had at least one component of complement deficiency. Ten patients (27%) had low C1q level, 11 patients (30.5%) had low C2, nine patients (25%) had low C3, and four patients (11%) had low C4 level. Serum level of complement in pSLE was significantly lower than the control group, except C4 (P = 0.005). The low C1q patients had an earlier age of onset of disease (P < 0.0001). The cutaneous manifestations were more frequent and much more severe in pSLE with low complement (100% vs. 73%). The frequency of renal and musculoskeletal symptoms was equal, but renal morbidity was more common in pSLE with low complement. Positivity for anti-ds-DNA was less common in pSLE with low complement (71% vs. 86%).
Conclusion: In pSLE patients with early disease onset and more aggressive SLE manifestations and negative anti-ds-DNA test, complement deficiency should be considered.
Keywords: C1q deficiency; childhood-onset; children; complement deficiency; systemic lupus erythematosus.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Early Complement Component Deficiency in a Single-Centre Cohort of Pediatric Onset Lupus.J Clin Immunol. 2015 Nov;35(8):777-85. doi: 10.1007/s10875-015-0212-y. Epub 2015 Nov 13. J Clin Immunol. 2015. PMID: 26563161
-
Exome sequencing revealed C1Q homozygous mutation in Pediatric Systemic Lupus Erythematosus.Allergol Immunopathol (Madr). 2018 Nov-Dec;46(6):594-598. doi: 10.1016/j.aller.2018.02.004. Epub 2018 May 5. Allergol Immunopathol (Madr). 2018. PMID: 29739689
-
Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus.Arthritis Res Ther. 2015 Jun 17;17(1):162. doi: 10.1186/s13075-015-0682-6. Arthritis Res Ther. 2015. PMID: 26081107 Free PMC article.
-
Classical pathway deficiencies - A short analytical review.Mol Immunol. 2015 Nov;68(1):14-9. doi: 10.1016/j.molimm.2015.05.007. Epub 2015 May 30. Mol Immunol. 2015. PMID: 26038300 Review.
-
The hereditary and acquired deficiencies of complement.Med Clin North Am. 1985 May;69(3):487-504. doi: 10.1016/s0025-7125(16)31028-8. Med Clin North Am. 1985. PMID: 3892188 Review.
Cited by
-
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE.Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI210-SI225. doi: 10.1093/rheumatology/keac275. Rheumatology (Oxford). 2023. PMID: 35532072 Free PMC article.
-
Complex medical history of a patient with a compound heterozygous mutation in C1QC.Lupus. 2019 Sep;28(10):1255-1260. doi: 10.1177/0961203319865029. Epub 2019 Jul 29. Lupus. 2019. PMID: 31357913 Free PMC article.
-
Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective.Immunogenetics. 2019 Apr;71(4):283-297. doi: 10.1007/s00251-019-01103-2. Epub 2019 Jan 22. Immunogenetics. 2019. PMID: 30671674 Review.
-
Childhood-Onset Systemic Lupus Erythematosus Presenting With Concomitant Gastrointestinal Manifestation and Antiphospholipid Syndrome.Cureus. 2023 Nov 21;15(11):e49205. doi: 10.7759/cureus.49205. eCollection 2023 Nov. Cureus. 2023. PMID: 38024034 Free PMC article.
-
Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous.Open Life Sci. 2024 Feb 8;19(1):20220812. doi: 10.1515/biol-2022-0812. eCollection 2024. Open Life Sci. 2024. PMID: 38465338 Free PMC article.
References
-
- Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929–39. - PubMed
-
- Ståhl-Hallengren C, Jönsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27:685–91. - PubMed
-
- Kaufman DB, Laxer RM, Silverman ED, Stein L. Systemic lupus erythematosus in childhood and adolescence-the problem, epidemiology, incidence, susceptibility, genetics, and prognosis. Curr Probl Pediatr. 1986;16:545–625. - PubMed
-
- Taddio A, Rossetto E, Rosé CD, Brescia AM, Bracaglia C, Cortis E, et al. Prognostic impact of atypical presentation in pediatric systemic lupus erythematosus: Results from a multicenter study. J Pediatr. 2010;156:972–7. - PubMed
-
- Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz LK, et al. Hereditary C1q deficiency and systemic lupus erythematosus. QJM. 1994;87:455–64. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous